Back to Search Start Over

Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming.

Authors :
Wang, Dayuan
Gu, Xiao
Ma, Xinyi
Chen, Jun
Zhang, Qizhi
Yu, Zhihua
Li, Juan
Hu, Meng
Tan, Xiaofang
Tang, Yuyun
Xu, Jianrong
Xu, Minjun
Song, Qingxiang
Song, Huahua
Jiang, Gan
Tang, Zaiming
Gao, Xiaoling
Chen, Hongzhuan
Source :
Acta Pharmaceutica Sinica B; Feb2023, Vol. 13 Issue 2, p834-851, 18p
Publication Year :
2023

Abstract

Microglial surveillance plays an essential role in clearing misfolded proteins such as amyloid-beta, tau, and α -synuclein aggregates in neurodegenerative diseases. However, due to the complex structure and ambiguous pathogenic species of the misfolded proteins, a universal approach to remove the misfolded proteins remains unavailable. Here, we found that a polyphenol, α -mangostin, reprogrammed metabolism in the disease-associated microglia through shifting glycolysis to oxidative phosphorylation, which holistically rejuvenated microglial surveillance capacity to enhance microglial phagocytosis and autophagy-mediated degradation of multiple misfolded proteins. Nanoformulation of α -mangostin efficiently delivered α -mangostin to microglia, relieved the reactive status and rejuvenated the misfolded-proteins clearance capacity of microglia, which thus impressively relieved the neuropathological changes in both Alzheimer's disease and Parkinson's disease model mice. These findings provide direct evidences for the concept of rejuvenating microglial surveillance of multiple misfolded proteins through metabolic reprogramming, and demonstrate nanoformulated α -mangostin as a potential and universal therapy against neurodegenerative diseases. NP- α -M rejuvenates microglial surveillance of misfolded proteins through metabolic reprogramming, which provides a universal approach to clear multiple misfolded proteins and treat neurodegenerative diseases. [Display omitted] [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22113835
Volume :
13
Issue :
2
Database :
Supplemental Index
Journal :
Acta Pharmaceutica Sinica B
Publication Type :
Academic Journal
Accession number :
162009409
Full Text :
https://doi.org/10.1016/j.apsb.2022.07.014